Fig. 3From: A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in UgandaResults of the non-inferiority test for the primary efficacy by study populationBack to article page